Get started
Author

Christian Michael Squillante

Observed names: C. Squillante, C.M. Squillante, Christian M. Squillante, Christian Squillante
Observed institutions: Allina Health, Hospital of the University of Pennsylvania, Cooper University Hospital, University of Pennsylvania Health System, Cooper Norcross Health, Abramson Cancer Center, University of Pennsylvania
OpenAlex ID: A5040461017
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study
2024 · Robert J. Motzer, Camillo Porta, et al. · Journal of Clinical Oncology · 186
Cabozantinib in combination with atezolizumab in non-small cell lung cancer (NSCLC) patients previously treated with an immune checkpoint inhibitor: Results from cohort 7 of the COSMIC-021 study.
2020 · Joel W. Neal, Farah Louise Lim, et al. · Journal of Clinical Oncology · 32
Cabozantinib in combination with atezolizumab in patients with metastatic castration-resistant prostate cancer: Results of cohort 6 of the COSMIC-021 study.
2020 · Neeraj Agarwal, Yohann Loriot, et al. · Journal of Clinical Oncology · 32
Atezolizumab-induced Encephalitis in Metastatic Bladder Cancer: A Case Report and Review of the Literature
2017 · Jeffrey J. Levine, Robert A. Somer, et al. · Clinical Genitourinary Cancer · 30
The Impact of Worry on Attention to Threat
2010 · Desmond J. Oathes, Christian M. Squillante, et al. · PLoS ONE · 24
PDF
Cabozantinib (C) in combination with atezolizumab (A) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Results of Cohort 6 of the COSMIC-021 Study.
2020 · Neeraj Agarwal, Yohann Loriot, et al. · Journal of Clinical Oncology · 21
A phase II trial of cabozantinib (CABO) for the treatment of radioiodine (RAI)-refractory differentiated thyroid carcinoma (DTC) in the first-line setting.
2018 · Marcia S. Brose, Sangeeta Shenoy, et al. · Journal of Clinical Oncology · 21
A phase II study of everolimus (E) and sorafenib (S) in patients (PTS) with metastatic differentiated thyroid cancer who have progressed on sorafenib alone.
2015 · Marcia S. Brose, Andrea B. Troxel, et al. · Journal of Clinical Oncology · 21
Stereotactic Body Radiotherapy Treatment for Recurrent, Previously Irradiated Head and Neck Cancer
2018 · Luke Stanisce, Yekaterina Koshkareva, et al. · Technology in Cancer Research & Treatment · 18
Targeted therapies in germ cell tumors
2014 · Christian M. Squillante, David J. Vaughn · Urologic Oncology Seminars and Original Investigations · 11
FP14.08 Cabozantinib Plus Atezolizumab in NSCLC Patients Previously Treated with a Checkpoint Inhibitor: Results from COSMIC 021
2021 · J. Neal, F. Lim, et al. · Journal of Thoracic Oncology · 6
PDF
A Phase 2 Trial of Cabozantinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Carcinoma in the First-Line Setting
2018 · M.S. Brose, S. Shenoy, et al. · International Journal of Radiation Oncology*Biology*Physics · 5
Association Among Hypoxemia, Patent Foramen Ovale, and Mediastinal Germ Cell Tumor: A Case Report
2015 · Michael D. Offin, Jonathan Menachem, et al. · Annals of Internal Medicine · 4
Multi-Institutional Patterns of Use of Tumor-Treating Fields for Patients with Malignant Pleural Mesothelioma
2023 · Tugce Kutuk, Joshua M. Walker, et al. · Current Oncology · 2
PDF
Risk-Stratified Initial Salvage Therapy for Relapsed or Refractory Metastatic Germ Cell Tumors
2016 · Vivek Narayan, Orvar Gunnarsson, et al. · Clinical Genitourinary Cancer · 2
Stereotactic body radiotherapy and systemic dose chemotherapy for locally advanced lung cancer, single-arm phase II study.
2020 · Greg Kubicek, Polina Khrizman, et al. · Journal of Clinical Oncology · 1
EP07.01-019 Multiinstitutional Patterns of Use and Compliance with Tumor Treating Fields for Patients with Unresectable Malignant Pleural Mesothelioma
2022 · T. Kutuk, J. Walker, et al. · Journal of Thoracic Oncology
Abstract CT035: Safety, preliminary efficacy and pharmacodynamic (PD) analysis of maveropepimut-S, intermittent low-dose cyclophosphamide and pembrolizumab in patients with advanced, metastatic bladder cancer
2022 · Olivier Rixe, Vincent Castonguay, et al. · Cancer Research
SUN-491 A Diagnosis of Thyroid Cancer Reveals a Triple Threat
2020 · Samuel Lee Dengler, Lisa Reid, et al. · Journal of the Endocrine Society
PDF
SUN-505 The Invincible Parathyroid Gland
2019 · Mabel Mayorga, Christian Squillante, et al. · Journal of the Endocrine Society
Risk-stratified treatment of patients with metastatic germ cell tumor with progression after first-line therapy.
2015 · Orvar Gunnarsson, Wei-Ting Hwang, et al. · Journal of Clinical Oncology
Works count: 21
Citation count: 416
H-index: 10
I10-index: 10
Year
Topic
Type